D8 Super Store Review: A Catalogue With 93 Days Left

1. The store outgrew its own name, into the category about to be closed

We pulled 500 products from the store's public catalogue API and counted what the product names actually say. THCA: 186. THCP: 56. Delta-9: 17. Delta-8 — the substance in the company's name and domain — appears in three. Whatever this business was in 2021, it is now a THCA retailer.

That migration is the whole regulatory story in miniature. THCA is tetrahydrocannabinolic acid, the form the plant actually produces. It is not intoxicating as it sits in the jar. Apply heat — a lighter, a vape coil, an oven — and it decarboxylates into delta-9 THC. So a THCA flower product can pass a delta-9 dry-weight test in the package and deliver conventional cannabis to the person smoking it. That is not a loophole anybody discovered by accident; it is the industry's central adaptation to the 2018 Farm Bill.

Section 781 closes it directly, by defining hemp on total THC — the sum that includes THCA — rather than delta-9 alone, and by capping total THC at 0.4 mg per innermost retail container. A container limit measured in fractions of a milligram is not a restriction this catalogue can be reformulated to meet. A single THCA preroll or vape contains grams of material at high THCA percentage. The gap is not close enough to argue about.

2. Potency with no ceiling

In a regulated adult-use market, an edible package is typically capped at 100 mg of THC and divided into 10 mg servings, because that is roughly where regulators concluded a naive consumer stops having a good time. Those caps are the product of state rulemaking, dosing incidents and emergency-room data.

Here, the top of the range is a 16,000 mg pack. To the seller's credit the listing is specific about what that means — 800 mg per gummy, twenty per bag, blending delta-8, delta-9, HHC, CBD and THCP. We would rather have that number than not. But 800 mg in one piece is about eighty standard servings, and it contains THCP, a cannabinoid whose CB1 binding affinity is reported at roughly thirty times that of delta-9 and for which there is almost no human dosing literature. The blend is stated in total milligrams, so the buyer cannot tell how much of that 800 mg is the most potent ingredient.

Fifteen-thousand and twelve-thousand milligram packs appear repeatedly through the range. Nothing about this is illegal today. It is simply far outside the envelope that every regulated cannabis market in the country has independently concluded is sensible, sold without the counter staff, the ID scan at point of sale, or the dosing conversation those markets require.

3. The GLP-1 interaction worth reading twice

Start with the obvious one. THC drives appetite through CB1 receptor signalling; the effect is well enough established to have a colloquial name. A GLP-1 receptor agonist suppresses appetite. Combining them means paying for two agents working against each other, and the drug you are paying $149 to $499 a month for is the one being undermined.

The less obvious interaction is pharmacokinetic, and it is the one that could actually hurt someone. Semaglutide and tirzepatide slow gastric emptying substantially — it is a core part of the mechanism and the reason for the early satiety and reflux people report. An oral edible is not absorbed in the stomach; it has to pass into the small intestine, be absorbed, and undergo first-pass hepatic metabolism, which for THC produces 11-hydroxy-THC, a metabolite generally considered more potent than the parent compound. Every step downstream of the stomach waits on the stomach.

So the normal 30-to-90-minute onset a person has learned to expect may stretch well beyond it on a GLP-1, unpredictably, depending on when they last ate and where they are in their dosing week. The failure mode writes itself: nothing has happened after two hours, so take another. Then gastric emptying resumes and both doses arrive together — at these concentrations, potentially well over a gram of blended cannabinoids. Acute cannabis overconsumption is rarely dangerous in the physiological sense, but it produces genuine panic, tachycardia and emergency visits, and it is entirely avoidable.

One more overlap worth naming: cannabinoid hyperemesis syndrome causes cyclic vomiting in heavy long-term cannabis users, and it is frequently misdiagnosed for years. Nausea and vomiting are also common GLP-1 side effects. Someone on both who develops recurrent vomiting has two plausible explanations and needs a clinician to disentangle them, because the treatment for one is stopping cannabis and the treatment for the other is not.

4. Naming, and where we had to correct ourselves

Six products carry ketamine-evoking names — KetaKapz, KetaKapz Party Capsules, ketaMIND. We expected to find a product implying it contained a controlled dissociative and saying nothing about what was actually inside. That is not what the pages say. The ketaMIND listing states the formula works without THC, hemp, kratom or psilocybin, and names its active as Rhizoma Corydalis extract, specifically 13-OH Corydalis Yanhusuo with encapsulated piperine. Ketamine appears nowhere in 500 products. The disclosure is real and we credit it.

What remains is the name. Calling a corydalis tablet KetaKapz Party Capsules invites an inference the ingredients do not support, in the same way a patch called GLP-1 invites one. And corydalis is not a neutral filler: it contains tetrahydropalmatine, which has sedative and dopamine-antagonist activity, has been associated with case reports of hepatotoxicity, and is not something to take casually alongside other centrally-acting drugs.

The mushroom products are murkier and we could not resolve them. Microdot Magic Mushroom Tablets promise euphoric, focus-enhancing effects while describing their contents as premium functional mushrooms — a phrase that ordinarily denotes lion's mane, reishi and cordyceps, none of which are psychoactive. Amanita and muscaria appear four times each across the catalogue and muscimol not at all, so we cannot tell you whether these contain an Amanita preparation, a non-psychoactive blend, or something else. That ambiguity is the finding. A consumer buying something branded Magic Mushroom should be able to determine what is in it.

What is actually happening on 12 November 2026?

Section 781 of the 2026 appropriations law redefines hemp on a total-THC basis that includes THCA and other THC isomers, and imposes a limit of 0.4 mg of total THC per innermost retail container. The 2018 Farm Bill test — under 0.3% delta-9 THC by dry weight — is what the entire intoxicating hemp industry was built on, and it is being replaced. As of the date of this review that is 93 days away. The overwhelming majority of what this store sells cannot meet a 0.4 mg per-container cap.

Is this still a delta-8 store?

Barely. We sampled 500 products from the store's own catalogue API and counted the substance classes in product names: THCA appeared 186 times, THCP 56, delta-9 17, and delta-8 just 3. The business has migrated almost entirely to THCA, which is non-intoxicating in the package and converts to delta-9 THC when you heat it. That conversion is precisely what a total-THC standard captures, which is why this category is the one Section 781 is aimed at.

How strong are these products compared with a legal dispensary?

Far stronger, and it is not close. Regulated adult-use markets typically cap edibles at 10 mg of THC per serving and 100 mg per package. This store lists gummies at 16,000 mg per pack — the product page states 800 mg of a cannabinoid blend per gummy across 20 gummies, combining delta-8, delta-9, HHC, CBD and THCP. Several other packs are listed at 15,000 mg and 12,000 mg. An 800 mg piece is around eighty times a standard regulated serving.

What is THCP and should I worry about it?

Tetrahydrocannabiphorol is a cannabinoid with a longer alkyl side chain than delta-9 THC, and it binds the CB1 receptor far more strongly — reported in the region of thirty times the affinity. It appeared in 56 of the 500 product names we sampled. There is very little human data on it, no established dosing, and it is routinely blended into products whose total milligram figure does not tell you how much THCP you are getting. If you are new to any of this, blends containing it are the wrong place to start.

Are the “magic mushroom” products psilocybin?

No, and what they are instead is unclear, which is our objection. The Microdot Magic Mushroom Tablets describe premium functional mushrooms — a phrase that normally means lion's mane, reishi or cordyceps, none of which are psychoactive — while the branding promises euphoric, focus-enhancing effects. Across 500 products, psilocybin appeared 16 times (largely in statements that products do not contain it), amanita and muscaria four times each, and muscimol not at all. A buyer cannot tell from the listing what psychoactive substance, if any, they are purchasing.

What about the ketamine-sounding products?

They are not ketamine, and to be fair to the seller they say so clearly. The ketaMIND listing states the blend works without THC, hemp, kratom or psilocybin, and names its actual active: Rhizoma Corydalis extract, specifically 13-OH Corydalis Yanhusuo with piperine. The word ketamine appears zero times across the 500 products we sampled. Our criticism is narrower: the name evokes a controlled dissociative anaesthetic that the product does not contain, which is the naming doing work the ingredients do not. Corydalis is also not inert — its tetrahydropalmatine content has sedative and dopamine-antagonist activity and case reports of liver injury.

Does any of this interact with a GLP-1?

Two ways, and the second is the one nobody writes about. First, THC stimulates appetite through CB1 receptor activity, which directly opposes what semaglutide or tirzepatide is doing — you are paying for two things that fight each other. Second, GLP-1 receptor agonists substantially slow gastric emptying, and the onset of an edible depends on your stomach emptying into the small intestine. On a GLP-1, an edible may do nothing for far longer than you expect. The temptation is to take another. Then both arrive together.

Is buying here legal where I live?

That depends on your state and it is changing quickly. A substantial number of states have already restricted or banned intoxicating hemp-derived cannabinoids including delta-8 and THCA, and others regulate them through their cannabis programmes. Federal legality under the 2018 Farm Bill never overrode state law, and after 12 November 2026 the federal position changes too. Check your own state's current rules before ordering, and be aware that products bought before the deadline do not become legal to possess simply because you bought them earlier.